Drugs and Devices

FDA approves new drugs

  • ·On Dec. 16, the U.S. Food and Drug Administration (FDA) approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. Read more.
  • On Dec. 15, the FDA approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide. Read more.

Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares